230
Participants
Start Date
March 21, 2024
Primary Completion Date
June 30, 2027
Study Completion Date
June 30, 2032
Arlocabtagene Autoleucel
Specified dose on specified days
RECRUITING
Royal Prince Alfred Hospital, Camperdown
NOT_YET_RECRUITING
Local Institution - 0074, Melbourne
NOT_YET_RECRUITING
Local Institution - 0076, Melbourne
NOT_YET_RECRUITING
Local Institution - 0075, Brisbane
RECRUITING
Icahn School of Medicine at Mount Sinai, New York
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
RECRUITING
Roswell Park Cancer Institute, Buffalo
NOT_YET_RECRUITING
Local Institution - 0070, Philadelphia
WITHDRAWN
Local Institution - 0065, Baltimore
RECRUITING
Virginia Oncology Associates, Norfolk
RECRUITING
University of North Carolina Medical Center, Chapel Hill
WITHDRAWN
Local Institution - 0067, Charlotte
RECRUITING
Winship Cancer Institute of Emory University, Atlanta
RECRUITING
Northside Hospital, Atlanta
RECRUITING
Mayo Clinic in Florida, Jacksonville
RECRUITING
Miami Cancer Institute at Baptist Health, Inc., Miami
RECRUITING
Moffitt Cancer Center, Tampa
RECRUITING
Tennessee Oncology, Nashville
RECRUITING
Vanderbilt University Medical Center, Nashville
RECRUITING
Norton Women's and Children's Hospital, Louisville
RECRUITING
The James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center, Columbus
RECRUITING
Oncology Hematology Care, Cincinnati
RECRUITING
University of Iowa, Iowa City
RECRUITING
University Hospital and UW Health Clinics, Madison
RECRUITING
Mayo Clinic in Rochester, Minnesota, Rochester
RECRUITING
Northwestern Memorial Hospital, Chicago
RECRUITING
University of Chicago Medical Center, Chicago
RECRUITING
Washington University School of Medicine, St Louis
RECRUITING
The University of Kansas Cancer Center - Westwood, Westwood
RECRUITING
University of Arkansas for Medical Sciences, Little Rock
RECRUITING
UT Southwestern Medical Center, Dallas
RECRUITING
University of Texas MD Anderson Cancer Center, Houston
RECRUITING
Methodist HealthCare System of San Antonio Clinical Trials Office, Texas Transplant Institute, San Antonio
WITHDRAWN
Local Institution - 0069, Austin
RECRUITING
Colorado Blood Cancer Institute, Denver
RECRUITING
LDS Hospital, Salt Lake City
RECRUITING
Banner MD Anderson Cancer Center, Gilbert
RECRUITING
UCLA Hematology/Oncology - Westwood (Building 200 Suite 214), Los Angeles
RECRUITING
UCSF Helen Diller Medical Center at Parnassus Heights, San Francisco
RECRUITING
Oregon Health and Science University, Portland
RECRUITING
Fred Hutchinson Cancer Center, Seattle
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Massachusetts General Hospital, Boston
RECRUITING
Dana-Farber Cancer Institute, Boston
RECRUITING
Rutgers Cancer Institute of New Jersey, New Brunswick
RECRUITING
Tom Baker Cancer Center, Calgary
RECRUITING
McGill University Health Centre, Montreal
RECRUITING
Nagoya City University Hospital, Nagoya
RECRUITING
Hyogo Medical University Hospital, Nishinomiya
RECRUITING
Chiba University Hospital, Chiba
RECRUITING
University Hospital,Kyoto Prefectural University of Medicine, Kyoto
RECRUITING
Japanese Red Cross Medical Center, Tokyo
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
INDUSTRY